MedTrace Logo

Frusemide Infusion for the Prevention of Deterioration in Renal Function Post Cardiac Surgery.

NCT00246675 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-04-27

No results posted yet for this study

Summary

The purpose of the project is to test whether or not the commonly used medication frusemide, given after heart surgery, and aiming to increase urinary output can have an effect on kidney function.

Conditions

  • Renal Impairment After Cardiac Surgery

Interventions

DRUG

Frusemide

Sponsors & Collaborators

  • Melbourne Health

    lead OTHER

Principal Investigators

  • John F Cade · Royal Melbourne Hospital, Intensive Care Unit

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00246675 on ClinicalTrials.gov